218 related articles for article (PubMed ID: 18471519)
1. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.
Sureban SM; May R; George RJ; Dieckgraefe BK; McLeod HL; Ramalingam S; Bishnupuri KS; Natarajan G; Anant S; Houchen CW
Gastroenterology; 2008 May; 134(5):1448-58. PubMed ID: 18471519
[TBL] [Abstract][Full Text] [Related]
2. Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells.
Löblein MT; Falke I; Eich HT; Greve B; Götte M; Troschel FM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768932
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.
Troschel FM; Minte A; Ismail YM; Kamal A; Abdullah MS; Ahmed SH; Deffner M; Kemper B; Kiesel L; Eich HT; Ibrahim SA; Götte M; Greve B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245259
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21
Troschel FM; Palenta H; Borrmann K; Heshe K; Hua SH; Yip GW; Kiesel L; Eich HT; Götte M; Greve B
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3299-3312. PubMed ID: 34291358
[TBL] [Abstract][Full Text] [Related]
5. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
6. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
7. The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.
Götte M; Greve B; Kelsch R; Müller-Uthoff H; Weiss K; Kharabi Masouleh B; Sibrowski W; Kiesel L; Buchweitz O
Int J Cancer; 2011 Oct; 129(8):2042-9. PubMed ID: 21165952
[TBL] [Abstract][Full Text] [Related]
8. Suppression of intestinal tumorigenesis in
Wolfe AR; Ernlund A; McGuinness W; Lehmann C; Carl K; Balmaceda N; Neufeld KL
J Cell Sci; 2017 Feb; 130(4):805-813. PubMed ID: 28082422
[TBL] [Abstract][Full Text] [Related]
9. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas.
Fan LF; Dong WG; Jiang CQ; Xia D; Liao F; Yu QF
Int J Colorectal Dis; 2010 Jan; 25(1):17-23. PubMed ID: 19714342
[TBL] [Abstract][Full Text] [Related]
10. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.
Pastò A; Serafin V; Pilotto G; Lago C; Bellio C; Trusolino L; Bertotti A; Hoey T; Plateroti M; Esposito G; Pinazza M; Agostini M; Nitti D; Amadori A; Indraccolo S
Cancer Res; 2014 Apr; 74(7):2106-18. PubMed ID: 24525742
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract][Full Text] [Related]
12. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism.
Sureban SM; May R; Ramalingam S; Subramaniam D; Natarajan G; Anant S; Houchen CW
Gastroenterology; 2009 Aug; 137(2):649-59, 659.e1-2. PubMed ID: 19445940
[TBL] [Abstract][Full Text] [Related]
13. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
[TBL] [Abstract][Full Text] [Related]
15. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2.
Subramaniam D; Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1025-32. PubMed ID: 18292181
[TBL] [Abstract][Full Text] [Related]
16. Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury.
George RJ; Sturmoski MA; May R; Sureban SM; Dieckgraefe BK; Anant S; Houchen CW
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G245-54. PubMed ID: 19056768
[TBL] [Abstract][Full Text] [Related]
17. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.
Sureban SM; Ramalingam S; Natarajan G; May R; Subramaniam D; Bishnupuri KS; Morrison AR; Dieckgraefe BK; Brackett DJ; Postier RG; Houchen CW; Anant S
Oncogene; 2008 Jul; 27(33):4544-56. PubMed ID: 18427544
[TBL] [Abstract][Full Text] [Related]
18. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
19. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
